United Therapeutics (UTHR) FCF Margin Growth (3y) (2012 - 2026)
Powered by 
Analysis
United Therapeutics (UTHR) FCF Margin Growth (3y) (2012 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.93 Bn | 625.17 Bn | 17.26 Bn | 1,461.00 |
| 2 | AbbVie | 443.06 Bn | 436.49 Bn | 12.70 Bn | -2,596.00 |
| 3 | Merck | 365.76 Bn | 358.62 Bn | 12.21 Bn | 874.00 |
| 4 | Novartis Ag | 266.47 Bn | 258.78 Bn | 11.24 Bn | 982.00 |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | 1,832.00 |
| 6 | Sanofi | 52.36 Bn | 44.98 Bn | 10.79 Bn | 1,733.00 |
| 7 | Revolution Medicines | 43.97 Bn | 43.97 Bn | - | - |
| 8 | Incyte | 25.42 Bn | 20.88 Bn | 1.57 Bn | -176.00 |
| 9 | United Therapeutics | 21.52 Bn | 18.86 Bn | 683.80 Mn | 1,592.00 |
| 10 | Neurocrine Biosciences | 15.60 Bn | 15.21 Bn | 935.80 Mn | -2,476.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1,592.00 |
| Mar 31, 2026 | -1,941.00 |
| Dec 31, 2025 | 388.00 |
| Sep 30, 2025 | 719.00 |
| Jun 30, 2025 | -734.00 |
| Mar 31, 2025 | -1,095.00 |
| Dec 31, 2024 | 954.00 |
| Sep 30, 2024 | 366.00 |
| Jun 30, 2024 | -337.00 |
| Mar 31, 2024 | 2,903.00 |
| Dec 31, 2023 | -1,788.00 |
| Sep 30, 2023 | -1,582.00 |
| Jun 30, 2023 | -2,995.00 |
| Mar 31, 2023 | 921.00 |
| Dec 31, 2022 | -696.00 |
| Sep 30, 2022 | -601.00 |
| Jun 30, 2022 | -658.00 |
| Mar 31, 2022 | 23,953.00 |
| Dec 31, 2021 | 1,624.00 |
| Sep 30, 2021 | -1,100.00 |